Home Cart Sign in  
Chemical Structure| 2647442-13-3 Chemical Structure| 2647442-13-3

Structure of GS-621763
CAS No.: 2647442-13-3

Chemical Structure| 2647442-13-3

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

GS-621763 is an orally effective prodrug of GS-441524, demonstrating antiviral activity against SARS-CoV-2 in mice. It exhibits dose-dependent antiviral effects on the replication of SARS-CoV-2 reporter viruses.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of GS-621763

CAS No. :2647442-13-3
Formula : C24H31N5O7
M.W : 501.53
SMILES Code : N#C[C@]1(C2=CC=C3N2N=CN=C3N)[C@@H]([C@@H]([C@H](O1)COC(C(C)C)=O)OC(C(C)C)=O)OC(C(C)C)=O
MDL No. :N/A

Safety of GS-621763

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319
Precautionary Statements:P501-P270-P264-P280-P302+P352-P337+P313-P305+P351+P338-P362+P364-P332+P313-P301+P312+P330

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
Calu-3 2B4 cells 0.74 μM 48 hours Evaluate the antiviral activity of Molnupiravir against MERS-CoV, showing effective inhibition Sci Transl Med. 2022 May 4;14(643):eabm3410
NHBE cells 0.125 μM 24 hours Evaluate the inhibitory effect of Molnupiravir on SARS-CoV-2-fLUC replication in NHBE cells, showing effective inhibition Sci Transl Med. 2022 May 4;14(643):eabm3410

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
BALB/c mice SARS-CoV-2 MA10 infection model Oral 30 mg/kg or 60 mg/kg Twice daily for 4 days Evaluate the therapeutic effect of Molnupiravir in SARS-CoV-2 infected mouse model, showing significant reduction in viral load and lung pathology Sci Transl Med. 2022 May 4;14(643):eabm3410

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.99mL

0.40mL

0.20mL

9.97mL

1.99mL

1.00mL

19.94mL

3.99mL

1.99mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2
 

Historical Records

Categories